China Medical System Holdings Ltd banner

Intrinsic Value

The intrinsic value of China Medical System Holdings Ltd (2M7C) under the Base Case is 1.53 EUR per share. Compared with the current market price of 1.1 EUR, the stock appears Undervalued by 28% .

The intrinsic value is the average of valuations using the DCF method and multiples.

Do our valuations actually work? See backtest results .

2M7C Intrinsic Value
€1.53
Undervaluation 28%
Intrinsic Value
Price €1.1
C

2M7C is cheaper than usual. It was this cheap or cheaper on just 25% of days in the past 5 years.

Monitor 2M7C
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value €1.22
Get notified when the price drops into your buy zone
Intrinsic Value €1.53
Margin of Safety 20% €1.22
Current Price €1.1
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to 2M7C

Fundamental Analysis

What China Medical System Does

Pharmaceuticals Health Care

China Medical System Holdings is a pharmaceutical company that brings branded prescription medicines into mainland China and nearby markets, then helps register, market, and sell them. Its business is centered on a portfolio of drugs used in areas like cardiovascular care, skin disease, digestion, and other specialty treatments. It works with drug owners and healthcare providers to move products from regulatory approval to routine use by doctors and hospitals.

Headquarters
China CN
Employees
5 292
IPO date
Sep 28, 2010
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
China Medical System Holdings Ltd

Wall St Price Targets

Capital Returns

Competitive Landscape

What is the Intrinsic Value of one 2M7C stock?

The intrinsic value for China Medical System Holdings Ltd (2M7C) under the Base Case is 1.53 EUR.

Is 2M7C stock undervalued or overvalued?

Compared with the current market price of 1.1 EUR, the stock appears Undervalued by 28% .

Back to Top